Search research articles
Contact Us
Filters
Showing results (11-20 of 46) with videos related to
Page
of 5
Sort By:
Molecular Cancer
|
June 3, 2014
Combined targeting of TGF-β1 and integrin β3 impairs lymph node metastasis in a mouse model of non-small-cell lung cancer
Elizabeth Salvo, Saray Garasa, Javier Dotor, et al.
European Journal of Immunology
|
May 3, 2007
Role of TGF-beta and PGE2 in T cell responses during Plasmodium yoelii infection
Carlos Ocaña-Morgner, Kurt A Wong, Flavia Lega, et al.
Recent Patents on Cardiovascular Drug Discovery
|
January 29, 2008
Novel pharmacologic strategies to protect the liver from ischemia-reperfusion injury
María Iñiguez, Javier Dotor, Esperanza Feijoo, et al.
Cancer Immunology, Immunotherapy : CII
|
June 15, 2007
Combined immunization with adjuvant molecules poly(I:C) and anti-CD40 plus a tumor antigen has potent prophylactic and therapeutic antitumor effects
Diana Llopiz, Javier Dotor, Aintzane Zabaleta, et al.
Breast Cancer Research and Treatment
|
August 4, 2009
Soluble factors derived from tumor mammary cell lines induce a stromal mammary adipose reversion in human and mice adipose cells. Possible role of TGF-beta1 and TNF-alpha
Javier Guerrero, Nicolás Tobar, Mónica Cáceres, et al.
Cardiovascular Research
|
November 21, 2008
A synthetic peptide from transforming growth factor-beta1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats
Nerea Hermida, Begoña López, Arantxa González, et al.
Cancer Letters
|
July 31, 2016
P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines
Gabriel Gallo-Oller, Arabel Vollmann-Zwerenz, Bárbara Meléndez, et al.
Cancer Research
|
November 3, 2007
A role for endoglin as a suppressor of malignancy during mouse skin carcinogenesis
Eduardo Pérez-Gómez, María Villa-Morales, Javier Santos, et al.
Plos One
|
June 7, 2013
Transforming growth factor-beta inhibition reduces progression of early choroidal neovascularization lesions in rats: P17 and P144 peptides
Javier Zarranz-Ventura, Patricia Fernández-Robredo, Sergio Recalde, et al.
The Journal of Bone and Joint Surgery. American Volume
|
July 4, 2014
Improved Chondrogenic Capacity of Collagen Hydrogel-Expanded Chondrocytes: In Vitro and in Vivo Analyses
Patricia Sanz-Ramos, Julio Duart, María Victoria Rodríguez-Goñi, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 46) with videos related to
Sort By:
Page
of 5
Molecular Cancer
|
June 3, 2014
Combined targeting of TGF-β1 and integrin β3 impairs lymph node metastasis in a mouse model of non-small-cell lung cancer
Elizabeth Salvo, Saray Garasa, Javier Dotor, et al.
European Journal of Immunology
|
May 3, 2007
Role of TGF-beta and PGE2 in T cell responses during Plasmodium yoelii infection
Carlos Ocaña-Morgner, Kurt A Wong, Flavia Lega, et al.
Recent Patents on Cardiovascular Drug Discovery
|
January 29, 2008
Novel pharmacologic strategies to protect the liver from ischemia-reperfusion injury
María Iñiguez, Javier Dotor, Esperanza Feijoo, et al.
Cancer Immunology, Immunotherapy : CII
|
June 15, 2007
Combined immunization with adjuvant molecules poly(I:C) and anti-CD40 plus a tumor antigen has potent prophylactic and therapeutic antitumor effects
Diana Llopiz, Javier Dotor, Aintzane Zabaleta, et al.
Breast Cancer Research and Treatment
|
August 4, 2009
Soluble factors derived from tumor mammary cell lines induce a stromal mammary adipose reversion in human and mice adipose cells. Possible role of TGF-beta1 and TNF-alpha
Javier Guerrero, Nicolás Tobar, Mónica Cáceres, et al.
Cardiovascular Research
|
November 21, 2008
A synthetic peptide from transforming growth factor-beta1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats
Nerea Hermida, Begoña López, Arantxa González, et al.
Cancer Letters
|
July 31, 2016
P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines
Gabriel Gallo-Oller, Arabel Vollmann-Zwerenz, Bárbara Meléndez, et al.
Cancer Research
|
November 3, 2007
A role for endoglin as a suppressor of malignancy during mouse skin carcinogenesis
Eduardo Pérez-Gómez, María Villa-Morales, Javier Santos, et al.
Plos One
|
June 7, 2013
Transforming growth factor-beta inhibition reduces progression of early choroidal neovascularization lesions in rats: P17 and P144 peptides
Javier Zarranz-Ventura, Patricia Fernández-Robredo, Sergio Recalde, et al.
The Journal of Bone and Joint Surgery. American Volume
|
July 4, 2014
Improved Chondrogenic Capacity of Collagen Hydrogel-Expanded Chondrocytes: In Vitro and in Vivo Analyses
Patricia Sanz-Ramos, Julio Duart, María Victoria Rodríguez-Goñi, et al.
Page
of 5